5-​Pyrimidineethanethio​amide, 2-​butyl-​1,​6-​dihydro-​N,​N,​4-​trimethyl-​6-​oxo-​1-​[[2'-​(2H-​tetrazol-​5-​yl)​[1,​1'-​biphenyl]​-​4-​yl]​methyl]​- 2-丁基-1,6-二氢-N,N,4-三甲基-6-氧代-1-[[2'-( 2H-四唑-5-基)[1,1'-联苯]-4-基]甲基]-5-嘧啶乙硫酰胺

CAS 247257-48-3 MFCD47257483

化学结构图

247257-48-3
SMILES:

化学属性

Mol. FormulaC27H31N7OS

别名和识别编码

Chemical Name5-​Pyrimidineethanethio​amide, 2-​butyl-​1,​6-​dihydro-​N,​N,​4-​trimethyl-​6-​oxo-​1-​[[2'-​(2H-​tetrazol-​5-​yl)​[1,​1'-​biphenyl]​-​4-​yl]​methyl]​-
Chemical Name Translation2-丁基-1,6-二氢-N,N,4-三甲基-6-氧代-1-[[2'-( 2H-四唑-5-基)[1,1'-联苯]-4-基]甲基]-5-嘧啶乙硫酰胺
Chemicalbook IDCB22128722
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Chi YH, et al. Pharmacological characterization of BR-A-657, a highly potent nonpeptide angiotensin II receptor antagonist. Biol Pharm Bull. 2013;36(7):1208-15.
  • [3]. Lee HW, et al. Effect of age on the pharmacokinetics of fimasartan (BR-A-657). Expert Opin Drug Metab Toxicol. 2011 Nov;7(11):1337-44.
  • [4]. Shin KH, et al. The effect of the newly developed angiotensin receptor II antagonist fimasartan on the pharmacokinetics of atorvastatin in relation to OATP1B1 in healthy male volunteers. J Cardiovasc Pharmacol. 2011 Nov;58(5):492-9.
  • [1]. Ryu S, et al. Fimasartan, anti-hypertension drug, suppressed inducible nitric oxide synthase expressions via nuclear factor-kappa B and activator protein-1 inactivation. Biol Pharm Bull. 2013;36(3
  • [1]. Ryu S, et al. Fimasartan, anti-hypertension drug, suppressed inducible nitric oxide synthase expressions via nuclear factor-kappa B and activator protein-1 inactivation. Biol Pharm Bull. 2013;36(3):467-74.

系列性分类

  1. Medical Research Areas
  2. GPCR & G Protein
  3. Angiotensin Receptor  (血管紧张素受体)

相关产品推荐